Asia-Focused Biotech SPAC Valuence Merger I Prices US$200 Million IPO

Special purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq Global Market today. The firm aims to raise US$200.0 million in its initial public offering.

The offering consisted of 20.0 million company units at US$10.00 per unit. Each unit contains one Class A common share and one-half of a redeemable warrant. Each whole warrant is exercisable for one common share at US$11.50 per share. The company units are currently trading under the symbol “VMCAU” while the shares and purchase warrants, once trading separately, will be trading under “VMCA” and “VMCAW”, respectively.

SVB Leerink acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day overallotment option to purchase additional 3.0 million units at the same IPO price.

The blank check firm is being led by CEO Sung Yoon Woo, the CEO of South Korean private equity firm Credian Partners. The firm also expects to partner with venture capital firm CrystalBioSciences and Japan-based consulting firm Quantum Leaps,

For its target businesses, the firm said it intends to search for businesses “in Asia (excluding China, Hong Kong, and Macau) with a particular focus… in life sciences and/or sustainable technology.”


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Digital Gaming Firm Super Group Debuts On NYSE Thru Sports Entertainment Acquisition Merger

Online sports betting and gaming holdings firm SGHC (NYSE: SGHC), known as Super Group, is...

Friday, January 28, 2022, 02:24:00 PM

Radiation Oncology Firm Shuttle Pharmaceuticals Prices US$10 Million IPO

Pharmaceutical company focused on radiation therapy treatment Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) started trading...

Thursday, September 1, 2022, 02:21:00 PM

Tech SPAC AxonPrime Infrastructure Acquisition Conducts US$150 Million IPO

Special purpose acquisition company AxonPrime Infrastructure Acquisition Corporation (Nasdaq: APMIU) started trading publicly on the...

Monday, August 16, 2021, 10:49:00 AM

Former Apollo Global Exec-Led SPAC Beard Energy Transition Acquisition Prices US$200 Million IPO

Blank check company Beard Energy Transition Acquisition Corp. (NYSE: BRDU) went public yesterday on the...

Thursday, November 25, 2021, 02:08:00 PM

Biotech SPAC Larkspur Health Acquisition Prices US$75 Million IPO

After filing for registration in May 2021, special purpose acquisition company Larkspur Health Acquisition Corp....

Tuesday, December 21, 2021, 01:54:00 PM